The move to remove “potentially stigmatizing or invasive” questions was made to reduce the stigma associated with mental health in the healthcare field and connect workers with needed resources, according to a Dec. 11 news release from the Massachusetts Health and Hospital Association.
The effort was approved unanimously by the association’s board of trustees and was supported by the Massachusetts Medical Society along with local health plans, which each have their own credentialing forms for clinicians.
Meanwhile, the National Committee for Quality Assurance — the organization responsible for accrediting health plans across the country — is no longer requiring plans to ask clinicians about prior drug use.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
